Sign in
WithdrawnNo phase

Applications of MRI in Kidney Disease

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Status
Withdrawn
Started
30 Oct 2025
Expected to end
30 Aug 2028
Type of study
Observational, 3 groups
Treatments tested
  • No intervention but only observational
Record updated
25 March 2025
Why it stopped
due to the risk for the patient and later funding issues

Who can take part

Age
45 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • English-speaking as primary language
  • Able to complete an approximately 75 to 90 minute cognitive and/or physical tests
  • Capable to consent to studies

Who cannot take part

  • Active chemical dependence, such as alcohol, narcotics or other drugs
  • Renal transplant recipient at time of screening or baseline
  • Acute psychiatric illness that would impede cognitive testing
  • Chronic and acute pulmonary disease
  • Legally blind or unable to complete cognitive tests due to visual loss or deafness
  • Severe CI unable to complete the Modified Mini-Mental State Examination [3MSE]

Where in United States

  • University of Minnesota Medical CenterMinneapolis, United States

About the trial

What the trial wants to find out

This study has two major purposes:

Read full original descriptionShow less

1. To test developed multiple anatomic and functional MRI methods; 2. To evaluate the potentials of these MRI methods in the diagnosis, prognosis, and monitoring of the progression of renal dysfunction.

These purposes will be achieved by performing pilot studies with cohorts of patients.

The 3 groups in the trial

  • Non-CKD (Control)

    Patients without CKD (eGFR ≥ 60 ml/min/1.73 mm2) (non-CKD controls). No intervention but only observational.

    Treatment: No intervention but only observational

  • CKD (chronic kidney disease)

    Patients with Patients with moderate to severe CKD (eGFR ranging from 26 to 44 ml/min/1.73 mm2). No intervention but only observational.

    Treatment: No intervention but only observational

  • ESRD (end-stage renal disease)

    Patients with advanced CKD (eGFR \< 15 ml/min/1.73 mm2), preparing for or undergoing the standard thrice-weekly HD or standard PD treatment (end-stage renal disease (ESRD) patients). No intervention but only observational.

    Treatment: No intervention but only observational

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
25 March 2025